ORIGINAL RESEARCH article

Front. Med., 25 August 2022

Sec. Nephrology

Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.928567

Factors influencing the time-intensity curve analysis of contrast-enhanced ultrasound in kidney transplanted patients: Toward a standardized contrast-enhanced ultrasound examination

  • 1. Department of Nephrology, University of Regensburg, Regensburg, Germany

  • 2. Department of Radiology, Interdisciplinary Ultrasound, University of Regensburg, Regensburg, Germany

  • 3. Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital, Regensburg, Germany

Article metrics

View details

11

Citations

2,9k

Views

935

Downloads

Abstract

Background:

Time-intensity curve analysis (TIC analysis) based on contrast-enhanced ultrasound (CEUS) provides quantifiable information about the microcirculation of different tissues. TIC analysis of kidney transplantations is still a field of research, and standardized study protocols are missing though being mandatory for the interpretation of TIC parameters in the clinical context. The aim of this study was to evaluate the impact of different sizes and forms of regions of interest (ROIs) on the variance of different TIC parameters and the level of interoperator variance between the different ROI methods in kidney transplantations.

Methods:

In 25 renal transplanted patients, 33 CEUS of the transplanted kidney were performed, and TIC analysis with ROIs sized 5 mm2 (ROI5), 10 mm2 (ROI10), and ROIs circumscribing the outlines of anatomical regions (ROIAnat) were analyzed based on CEUS examination. The TIC analysis was repeated by a second independent operator for ROI5 and ROIAnat.

Results:

Statistical analysis revealed significant differences between TIC parameters of different ROI methods, and overall, the interoperator variance was low. But a greater ROI surface (ROI10) led to higher values of the intensity parameters A and AUC compared with ROI5 (p < 0.05). The difference in the ROI form led to high variation of certain TIC parameters between ROI5 and ROIAnat in the myelon [intraclass correlation coefficient (A, ICC = 0.578 (0.139–0.793); TIC parameter (TTP); and ICC = 0.679 (0.344–0.842) (p < 0.05)]. A mean variation of 1 cm of the depth of ROI5 in the cortex did not show significant differences in the TIC parameters, though there was an impact of depth of ROIAnat on the values of TIC parameters. The interoperator variance in the cortex was low and equal for ROI5 and ROIAnat, but increased in the myelon, especially for ROIAnat. Furthermore, the analysis revealed a strong correlation between the parameter AUC and the time interval applied for the TIC analysis in the cortex and myelon (r = 0.710, 0.674, p < 0.000).

Conclusion:

Our findings suggest the application of multiple ROIs of 5 mm2 in the cortex and medulla to perform TIC analysis of kidney transplants. For clinical interpretation of AUC, a standardized time interval for TIC analysis should be developed. After the standardization of the TIC analysis, the clinical predictive value could be investigated in further studies.

Introduction

Kidney transplantation is the treatment of choice for patients with end-stage renal disease besides various dialysis procedures (1). Compared with dialysis, patients after successful kidney transplantation benefit from a better quality of life, a higher functional level, and show longer survival (2, 3). With the eldering of society and advanced medical care, the mismatch between organ demand and availability is increasing. In this context, it is important to maintain the function of the allograft as long as possible. The main reason for long-term allograft loss is a combination of immunological and different non-immunological factors (4). In the context of immune responses, inflammation and degenerative changes occur and lead to changes in microcirculation and limitation of allograft function (5). Chronic allograft nephropathy often starts developing within the first year post-transplantation, (6) and until recently, the invasive biopsy is the gold standard for diagnostics. However, the utility of protocol biopsies is useful to determine the degree of chronic damage but is discussed controversially because of their invasive nature and is not performed in every transplant center (7). Recently, more and more progress was made in non-invasive methods to assess transplant function. In this study, especially, biomarkers in serum (8) and urine (9) have been developed. In the field of apparative diagnostics, there is a focus on modern MRI techniques (10) and CT perfusion imaging (11).

Contrast-enhanced ultrasound (CEUS) allows the description of the microcirculation of organs and is more and more used in the examination of kidneys and kidney transplants. Time-intensity curve analysis (TIC analysis) in kidney transplantation is a novel technique of perfusion analysis, and there are promising data that TIC analysis could provide useful information to determine the prognosis of allograft early and non-invasively (12, 13). TIC analysis allows the objective measurement of the contrast kinetics within a defined region of interests (ROIs) and therefore describes the microcirculation. Based on CEUS examination, perfusion parameters are calculated using integrated or external software that applies a perfusion model in a selected ROI in the kidney. The advantages of CEUS are its availability, low cost, and safe application without nephrotoxic effects, so this technique can be applied to a broad mass of patients, especially as chronic kidney disease is no contraindication in comparison to other perfusion imaging modalities, such as contrast-enhanced CT scans (14). Currently, results of TIC analysis are only comparable to a limited extent, and TIC analysis in kidney transplants is still considered a field of research (7). Numerous factors such as instrument settings during CEUS examination, application of contrast medium, patient-related data (i.e., blood pressure and body mass index), and different analysis software have been shown to influence perfusion parameters (1517). Although TIC analysis is an emerging field of research, there is neither clarification about the impact of size, form, and localization of the different ROIs nor do we know much about the interoperator variance of TIC analysis.

In this study, we evaluated different methods of TIC analysis in renal transplantations and compared different factors influencing the quality of the measurement parameters (e.g., depth of the kidney and length of the cine loop). By repeating the measurements by another investigator, we checked the interreader variance. The aim of this study was to develop a standardized TIC analysis protocol with low intraoperator and interoperator variance and high feasibility.

Materials and methods

Patients and contrast-enhanced ultrasound examination

Between May 2017 and January 2019, 25 patients aged from 22 to 79 years with kidney transplants (mean organ age since KTx 5.18 years) received 33 CEUS at the University Hospital Regensburg by an experienced sonographer. Kidney-transplanted patients (>18 years) with a stable graft function and a CEUS examination suiting the study protocol were included in the study. Patients with pathologies of the transplanted kidneys (e.g., infarction, renal artery stenosis, infection, and ureteral obstruction) and patients with unstable hemodynamics were excluded from the study. In addition, CEUS studies that did not meet the quality requirements for the subsequent TIC analysis (e.g., stable image and length) were also excluded. There were no significant differences in the hemodynamics (e.g., blood pressure and cardiac function) of the patients.

Before CEUS, a complete status of the transplanted kidney was obtained including a B-mode scan and color-coded Doppler sonography. CEUS was performed in the “low-MI technique” (MI, mechanical index) with MI values < 0.09 (12). The setting of depth, gain, and focus was adjusted to the optimal display, with focus at the deepest point of the transplant. After giving written informed consent, patients received a 1.5 ml bolus of ultrasound contrast agent (sulfur hexafluoride microbubbles, SonoVue§, Bracco, Italy) followed by a 10 ml saline flush via intravenous administration in the cubital vein. After the injection of the contrast agent was completed, a timer was started. All examinations, including TIC analysis, were stored digitally (DICOM format). CEUS examination and data collection were permitted by the Ethical Committee of the University of Regensburg (17-662-101_P1, 17-662-101_P2, and 17-662-101_P3).

Time-intensity curve analysis

TIC analysis was performed based on 33 CEUS examinations by two operators separately. Both operators were blinded to the clinical parameters and the transplant outcomes. To check the robustness of the investigation and the ease of application, the investigations were carried out by two operators with different levels of experience. Operator 1 was an advanced medical student, and Operator 2 was a nephrologist experienced in the field of CEUS. The analysis was carried out using the integrated software of Logiq E9 (GE Healthcare, United States). A mathematical model for typical “Wash-in” kinetics was used for curve fitting. The starting point of TIC analysis was set at the arrival of the contrast agent in the central artery of the kidney (18), and the end of TIC analysis was set after 60 s on average or TIC analysis was determined earlier by the end of the video clip. We applied three different methods of ROI to perform the TIC analysis.

ROI5 and ROI10 3–5 regions were placed in the renal cortex and the myelon, respectively. The shape is circular and has a fixed size of 5 mm2 in ROI5 and 10 mm2 in ROI10. TIC parameters of ROI5 and ROI10 were calculated as averages of the multiple ROIs (Figure 1A).

FIGURE 1

ROIAnat describes the anatomical region (i.e., the total kidney, the whole cortex, the upper and the lower cortex, and one representative myelon). The regions were identified in the B-Mode scan, and the anatomical outline was circumscribed. Therefore, the size of the regions varies from patient to patient but may reflect the size and quality of the transplanted organ (Figure 1B).

The internal device software calculated the intensity-related TIC parameters including A, AUC, Grad [in arbitrary units (a.u.)], and the time-related TIC parameter (TTP) [in seconds (s)] (Figure 1C). A second operator, an experienced CEUS examiner, repeated the 33 TIC analysis with ROI5 and ROIAnat methods in the cortex and myelon. We investigated the differences and correlations between TIC parameters derived from different ROI methods. Furthermore, we analyzed the impact of ROI depth and the time interval of TIC analysis on TIC parameters and compared the interoperator variance of ROI5 and ROIAnat between the two operators.

Statistics

Results were expressed as mean ± SD if not indicated otherwise. The differences between groups were compared using the Wilcoxon rank test and the Friedman test (paired samples). The intraclass correlation coefficient was calculated using a two-way mixed model and absolute agreement, and then classification by Koo and Li was applied (19). Pearson correlation analysis determined the relation between TIC parameters and the time interval of TIC analysis. A p-value of < 0.05 was considered significant. All data were analyzed using IBM SPSS Statistics version 25.0 (IBM, Armonk, NY, United States).

Results

Baseline characteristics

TIC analysis was performed based on 33 CEUS examinations of 25 renal transplants of different patients in the Department of Nephrology at the University Hospital Regensburg. Since the examination of the transplanted kidney was often carried out as part of ultrasound follow-up examinations (e.g., when checking for complicated kidney cysts), it occurred that seven patients received a second CEUS, and one patient received a third CEUS. The average patient age was 54.73 ± 13.66 years (22–79 years), and the majority were men (64%, 16 cases), and the average age of kidney transplant at CEUS was 5.18 ± 4.86 years (0.0–249 months). In 28 cases, laboratory data were available at the time point of the CEUS with a mean creatinine level of 2.53 ± 1.59 mg/dl and a mean eGFR (CKD-EPI) of 40.04 ± 25.28 ml/min/1.73 m2. For the CEUS examination, we included patients of all CKD stages (Table 1 and Figure 2).

TABLE 1

CEUS—n33
Male—n (%)16 (64%)
Patient age—years54.73 ± 13.66
Kidney transplant age—years5.18 ± 4.86
eGFR at CEUS—ml/min/1,73 m237,0 ± 23,0
Serum creatinine level—mg/dl2.53 ± 1.59

Patient baseline characteristics.

FIGURE 2

Influence of size and form of region of interest

First, we compared the TIC parameters of all methods, and most frequently, differences showed up between ROIAnat and ROI10. In the myelon the differences between ROI5 and ROI10 were significant but in view of the measured values, the difference was rather low with a deviation of the mean < 10% (ΔA = −1.24 ± 0.55 a.u.; ΔAUC = 29.98 ± 15.44 a.u.; p < 0.05), and the ICC remained high in cortex and myelon. Then, we compared the ROIs with fixed surface area (ROI5 and ROI10) to the ROIAnat method and found variations for TIC parameter Grad and AUC in the cortex and myelon. The ICC between ROI5 and ROIAnat decreased in the myelon for parameters A, TTP, and Grad, and if one considered not solely the IC coefficient but also the 95% confidence interval of ICC, the agreement between the two methods must be interpreted as bad (p < 0.05). Notably, ROI5 was the only method that measured differences between the cortex and myelon for all TIC parameters (Tables 24).

TABLE 2

ROIAnatROI5ROI10P-value
123
Cortex
A20.94 ± 6.1120.35 ± 5.8720.99 ± 6.860.3960.4320.574
TTP15.12 ± 6.1114.55 ± 5.1915.45 ± 7.110.1770.5500.526
AUC620.60 ± 294.99589.95 ± 278.88564.19 ± 312.390.1890.0980.026*
Grad1.44 ± 0.661.61 ± 0.661.54 ± 0.70.001*0.1910.145
Myelon
A18.90 ± 7.6319.07 ± 6.0420.31 ± 6.590.7550.025*0.145
TTP20.55 ± 7.6720.55 ± 7.6719.56 ± 7.780.7280.2800.782
AUC502.37 ± 284.65532.27 ± 292.62562.18 ± 308.060.3390.014*0.008*
Grad0.97 ± 0.441.09 ± 0.501.20 ± 0.650.1180.0950.019*

Differences in time-intensity curve (TIC) parameter between ROI5, ROI10, and ROIAnat.

p-value group: 1 = ROI5 vs. ROIAnat, 2 = ROI5 vs. ROI10, and 3 = ROI10 vs. ROIAnat (n = 33). A, AUC, Grad in a.u.; TTP in seconds.

* p < 0.05.

TABLE 3

ROI5 vs. ROIAnat
ROI5 vs. ROI10
ICC (95%–CI)P-valueICC (95%–CI)P-value
Cortex
A0.873 (0.745–0.937)0.0000.887 (0.772–0.944)0.000
TTP0.939 (0.876–0.970)0.0000.878 (0.754–0.939)0.000
AUC0.958 (0.916–0.979)0.0000.972 (0.943–0.986)0.000
Grad0.951 (0.831–0.981)0.0000.931 (0.862–0.966)0.000
Myelon
A0.679 (0.344–0.842)0.0010.928 (0.844–0.965)0.000
TTP0.578 (0.139–0.793)0.0090.859 (0.716–0.930)0.000
AUC0.941 (0.882–0.971)0.0000.983 (0.962–0.992)0.000
Grad0.757 (0.513–0.879)0.0000.881 (0.758–0.941)0.000

Intraclass correlation of ROI5 and ROIAnat and ROI5 and ROI10.

Intraclass correlation coefficient (ICC) classification: bad < 0.5, moderate 0.5–0.75, good 0.75–0.9, and excellent correlation > 0.9. TIC analysis was performed by operator 1 (n = 33). A, AUC, Grad in a.u.; TTP in seconds.

TABLE 4

CortexMyelonP-value
ROI5
A20.3519.070.007
TTP14.5520.550.000
AUC589.95532.270.001
Grad1.611.090.000
ROI10
A20.9920.310.480#
TTP15.4519.570.000
AUC564.89562.180.600#
Grad1.541.200.000
ROIAnat
A20.9418.900.098#
TTP15.2119.890.000
AUC610.61502.370.000
Grad1.440.970.000

Differences of TIC parameters between cortex and myelon.

#p > 0.05 (n = 33). A, AUC, Grad in a.u.; TTP in seconds.

Influence of the localization and depth of the regions of interest

We investigated the influence of depth of ROI on the TIC parameters. The standardized 5 mm2 ROIs no. 1–5 were placed in different regions of the cortex and ROI no. 5 was on average 1 cm deeper than ROI no. 1 (3.5 ± 1.3 cm vs. 4.5 ± 1.7 cm). Nevertheless, the TIC parameters derived by ROI no. 1–5 did not show significant differences (Table 5). Using the ROIAnat method, we investigated differences between ROI “upper/lower/total cortex.” The intensity parameters A and AUC were higher, and the TTP was prolonged in “lower” and “total cortex” vs. “upper cortex.” There were no differences for TIC parameter Grad (Figure 3 and Table 6).

TABLE 5

nr. 1nr. 5P-value
Depth in cm3.5 ± 1.34.5 ± 1.70.014*
A20.86 ± 6.5420.28 ± 6.310.875
TTP14.08 ± 5.9414.49 ± 4.820.652
AUC598.95 ± 291.21611.00 ± 273.590.597
Grad1.65 ± 0.671.6 ± 0.700.984

In ROI5, variation of ROIs in depth does not affect TIC parameter values.

Five regions of interest (ROIs) sized 5 mm2 were placed in the cortex at different distances from the ultrasound probe. The value “depths in cm” describes the distance between ROI in the parenchyma and the ultrasound probe measured in cm. The TIC parameters derived by ROI no. 1 did not differ significantly from TIC parameters derived by ROI no. 5 (Friedman test, p > 0.05), though ROI no. 5 was localized on average 1.05 cm deeper in the cortex than ROI no. 1 (p < 0.05). N = 31 (in two TIC analyses, just four ROIs could be placed sufficiently). A, AUC, Grad in a.u.; TTP in seconds.

*p < 0.05.

FIGURE 3

TABLE 6

Cortex
P-value
TotalUpperLower123
Depth in cm8.33 + 1.793.48 + 0.967.50 + 1.300.000*0.000*0.003*
A20.94 + 6.1119.54 + 5.9921.69 + 5.330.0550.014*0.313
TTP15.21 + 6.1114.47 + 4.4417.57 + 10.090.1470.1400.161
AUC610.61 + 294.99571.40 + 272.72613.82 + 302.250.024*0.0910.574
Grad1.44 + 0.661.48 + 0.701.36 + 0.690.7550.3040.416

Impact of depths in ROIAnat on TIC parameter values in the cortex.

p-value group: 1 = upper vs. total. 2 = upper vs. lower 3 = total vs. lower; A, AUC, Grad in a.u.; TTP in seconds.

*p < 0.05.

Interoperator variance

We investigated the interoperator variance of TIC analysis between two operators using ROI5 and ROIAnat methods. Apart from the TIC parameter Grad, which showed a slight bias of 0.14 between operators 1 and 2 in the myelon, there were no significant differences between the two operators (Table 7). Yet, in the myelon, the deviation between the two operators increased compared with the cortex and was generally higher with ROIAnat than with ROI5 (Table 8). The higher interoperator variance for method ROIAnat is especially reflected in a greater level of agreement (LoA) in the myelon for parameters A and TTP (Table 9 and Figure 4).

TABLE 7

ROI5
ROIAnat
O1O2P-valueO1O2P-value
Cortex
A20.53 ± 5.820.46 ± 6.720.49220.94 ± 6.1123.09 ± 8.210.067
TTP14.55 ± 5.1915.83 ± 6.550.08815.12 ± 6.1125.52 ± 6.430.911
AUC589.95 ±573.54 ±0.067610.62 ±655.14 ±0.210
277.87300.44294.99295.38
Grad1.61 ± 0.661.50 ± 0.710.0851.44 ± 0.661.45 ± 0.680.501
Myelon
A19.07 ± 6.0419.92 ± 7.350.42718.90 ± 7.6320.50 ± 8.680.313
TTP20.55 ± 7.6721.63 ± 6.740.48019.89 ± 6.5021.66 ± 8.740.166
AUC532.27 ±535.76 ±0.102502.37 ±538.71 ±0.837
292.62312.42284.65326.02
Grad1.09 ± 0.500.95 ± 0.360.013*0.97 ± 0.440.91 ± 0.360.503

Differences of TIC parameters between operators 1 and 2.

Wilcoxon rank test, *p < 0.05, n = 33. O1 = operator 1, O2 = operator 2; A, AUC, Grad in a.u.; TTP in seconds.

TABLE 8

ROI5
ROIAnat
ICC (95%–CI)P-valueICC (95%–CI)P-value
Cortex
A0.915 (0.828–0.958)0.0000.579 (0.162–0.791)0.007
TTP0.834 (0.665–0.918)0.0000.903 (0.802–0.953)0.000
AUC0.922 (0.843–0.961)0.0000.929 (0.855–0.965)0.000
Grad0.917 (0.829–0.959)0.0000.952 (0.902–0.977)0.000
Myleon
A0.738 (0.471–0.871)0.0000.717 (0.433–0.859)0.000
TTP0.824 (0.648–0.913)0.0000.543 (0.087–0.773)0.014
AUC0.879 (0.754–0.940)0.0000.880 (0.758–0.940)0.000
Grad0.752 (0.498–0.877)0.0000.701 (0.397–0.852)0.001

Intraclass correlation between TIC parameters of operators 1 and 2.

Intraclass correlation coefficient classification: bad < 0.5, moderate 0.5–0.75, good 0.75–0.9, excellent correlation > 0.9; A, AUC, Grad in a.u.; TTP in second.

TABLE 9

ROI5
ROIAnat
LoA (bias ± 1.96*SD)P-valueLoA (bias ± 1.96*SD)P-value
Cortex
A−0.11 ± 7.000,863−2.38 ± 15.190.091
TTP−1.28 ± 8.570.103−0.21 ± 7.410.761
AUC16.40 ± 307.920.552−30.98 ± 294.050.253
Grad0.12 ± 0.720.077−0.02 ± 0.570.710
Myelon
A−0.85 ± 12.030.432−1.60 ± 15.000.238
TTP−1.08 ± 10.920.273−1.76 ± 16.870.248
AUC−3.49 ± 394.290.921−36.35 ± 392.800.305
Grad0.14 ± 0.700.044*0.06 ± 0.750.378

Bland Altman statistics for ROI5 and ROIAnat.

p-value refers to bias (*p < 0.05); A, AUC, Grad in a.u.; TTP in seconds.

FIGURE 4

Influence of the time interval of the cine-loop

As TIC analysis was carried out retrospectively, the duration of CEUS video clips available for TIC analysis differed in some cases and resulted in a variation in time. This is due to the fact of slightly different circulation times between the patients. The mean time interval used for TIC analysis was 47.31 ± 15.18 s, and Table 10 shows a strong correlation between the time interval of TIC analysis and the TIC parameter AUC in the cortex and myelon (r = 0.710 and 0.674, p < 0.000). Compared with the correlation between AUC and the time interval, the correlation between TTP and time interval was not significant (r = 0.389, p > 0.05), and TIC parameters A and Grad did not correlate with the time interval at all.

TABLE 10

Correlation coefficient, r (P-value)
ATTPAUCGrad
Cortex−0.257 (0.149)−0.118 (0.513)0.710 (0.000*)0.287 (0.105)
Myelon−0.225 (0.208)0.389 (0.025*)0.674 (0.000*)−0.038 (0.833)

Pearson correlation coefficient between the time interval of TIC analysis and TIC parameters.

r > 0.5 is considered a strong correlation, *p < 0.05; A, AUC, Grad in a.u.; TTP in second.

Discussion

TIC analysis of kidney transplants is a promising field of research to detect early signs of organ dysfunction through reduced microperfusion, especially in the cortical region of the kidney transplant. Unfortunately, to date, there is no standardized protocol to measure the different TIC parameters in organs with different compartments, e.g., transplanted kidneys. In this study, we tried to determine the factors, which influence the value of TIC parameter analysis in kidney transplants.

In general, the ROI should be large enough to also allow the detection of heterogeneous perfusion signs (20, 21). To date, there is no standardized protocol for the size or form of ROI for TIC analysis in kidney transplants resulting in an inhomogeneous use of ROI mainly sized 5 or 10 mm2 (2226) of an anatomical outline (2732) or was clearly not indicated (3336). Table 11 gives an overview of the localization, size, and form of ROIs of various studies with CEUS in kidneys. Leinonen et al. reported an inverse correlation between the size of the ROI and the intensity parameters (37). This goes along with our results, suggesting size impacts, especially TIC parameters representing the signal intensity like A and AUC. We recommend using a size of 5 mm2 for various reasons. First, placement of up to five ROIs in cortex and myelon was in most cases possible with an ROI of 5 mm2. In comparison, with 10 mm2 in some cases, only three ROIs could be positioned, as the thin cortex did not allow the exact placement without including other structures, e.g., the medulla or vascular structures, and correct placement of ROI with 10 mm2 size was more time-consuming than the positioning of 5 mm2. Second, a greater surface of ROI makes it more likely to include vascular structures, e.g., AA. interlobares, AA. arcuatae, and AA. interlobularis in unnoticed manner, which should be avoided in the analysis, as this distorts the perfusion analysis of microcirculation (18, 37). The arteries show a faster and increased contrast enhancement, which then leads to significant changes in the TIC parameters in the ROIs. This could also be seen in our analysis. TIC parameters representing the signal intensity did not differ significantly in the cortex or the myelon by using ROI10 (area 10 mm2) probably because other anatomical structures were included in the area of 10 mm2.

TABLE 11

ReferencesROI formROI locationNumber of ROIs per regionUS-deviceSoftwareKinetics of CEUSAim of studyStudy size
Wang et al. (22)SquareCortex; myelon;1;1;IU 22 (Philips)QLAB (Philips)BolusEvaluate perfusion parameters 1–6 months after transplantation35
Yoon et al. (23)SquareCortex; myelon;3;3;IU 22 (Philips)QLAB (Philips)BolusEvaluate CEUS-parameters as predictors of outcome in acute kidney injury48
Liang et al. (24)CircularCortex; myelon; interlobar artery; segmental artery1;1;1;1;IU 22 (Philips)Sonoliver (TomTec Imaging Systems)BolusEvaluate CEUS in the assessment of renal allograft dysfunction57
Cai et al. (25)CircularCortex2;GE LOGIQ 9 (GE Healthcare)Device internal softwareBolusCompare TIC-parameters between normal graft and delayed graft function44
Jin et al. (26)CircularCortex2;GE LOGIQ 9 (GE Healthcare)Device internal softwareBolusReliability of CEUS on the diagnosis of acute (AR) or chronic rejection (CR) after renal transplantation79
Álvarez Rodríguez et al. (33)Circular (no size)Cortex; myelon, interlobar artery1;BolusAssess the effectiveness of CEUS in the early post-transplant period of kidneys15
Benozzi et al. (34)Circular (no size)Cortex; corticomedullary axis;2; 2;BolusCompare CEUS to doppler-US in detection of early graft dysfunction39
Fischer et al. (35)Circular (no size)Main artery; cortex; renal vein;1;1;1;Aplio (Toshiba)Device internal softwareBolusEvaluate kidney recipients in the early posttransplant phase by TIC-analysis22
Fischer et al. (36)Circular (no size)Main artery; interlobar artery; cortex; renal vein;1;1;1;1;Aplio (Toshiba)Device internal softwareBolusDetermine the value of CEUS in the assessment of early allograft dysfunction45
Schwenger et al. (27)Outline of the regionCortex1;ATL HDI 5000 (Philips)QLAB (Philips)Flash replenishmentFeasibility of CEUS detecting CAN in comparison to color doppler US26
Araújo and Suassuna (28)Outline of the regionCortex; myelon; segmental artery;1;1;1;Aplio 400 (Toshiba)Device internal softwareBolusDifferences of TIC-analysis between early and late graft dysfunction67
Brabrand et al. (29)Outline of the regionCortex; myelon;1; 1;Acuson Sequoia 512 (Siemens)nordicICE; nordic imaging labBolusEvaluate changes in perfusion with CEUS due to global hypoxia in piglets12
Jeong et al. (30)Outline of the regionCortex1;RS80A (Samsung Medison)VueBox§; BraccoBolusEvaluate clinical significance of CEUS in CKD24
Stock et al. (31)Outline of the regionCortex; myelon; interlobar artery3;2;1;IU 22 (Philips)VueBox§, BraccoBolusEvaluate renal perfusion with CEUS in cats with CKD57
Kihm et al. (32)Outline of the regionCortex1;ATL TDI 5000 (Philips)QLABFlash replenishmentEvaluate change in microperfusion due to ciclosporine A and tacrolimus by CEUS32

Comparison of different ROI-sizes and -forms used for the TIC-analysis in kidney transplants in different studies.

The next question was whether it is necessary to include an entire anatomical region within the TIC analysis or only a representative, preformed area within this region. The rationale for using anatomic ROIs was that in standardized sections of the transplanted kidney, the size and configuration of the anatomic region could also provide an additional indication of the future renal function, which cannot be provided by single standardized sections of the anatomic region. When it comes to the form of ROI, a preformed size of 5 mm2 offers more standardization than a freehand drawn outline of the anatomic region (ROIAnat). The high variation of TIC parameters between ROI5 and ROIAnat shows that both methods could not be used as equivalent. To decide on one of the two methods, we included the following aspects into consideration: first, the variation of TIC parameters especially within the myeloid structures between the ROI5 and ROIAnat could be explained by the non-myeloid structure being unintentionally included in the freehand drawn ROI. This is supported by the higher interoperator variance between operators 1 and 2 in the myelon for ROIAnat. Second, the area of ROIAnat varied, whereas the area of ROI5 was constant. As Leinonen et al. reported, an equal area of ROI is a necessary criterion for constant TIC analysis (37). So far, there is no literature that distinguished these two methods before, but our results recommend an application of multiple ROIs sized 5 mm2 for further TIC analysis.

Using ROI5, the average difference in depth between the single ROI with 5 mm2 was solely 1.0 cm and did not result in different TIC parameters. In contrast to that, with ROIAnat, there was an average difference of 4.5 cm that led to differences in TIC parameters. The method ROIAnat showed that not the size of ROI, but predominantly the depth of ROI influenced the values of intensity-related (A, AUC) and time-related TTP. It is up to the technique of ultrasound itself that signal attenuation correlates with distance to the ultrasound probe and may reflect in different values of TIC parameters (37). Nevertheless, with ROI5, we recommended placing the ROIs in well-perfused and distinct regions that are representative of the anatomic region and handle depth as a secondary criterion for the location of ROIs.

The CEUS examination should be performed only by experienced investigators (12, 38) and yet the performance and subsequent assessment of the CEUS examination are highly examiner-dependent. The most important thing to mention in this study is that the examination is carried out without movement and without pressure on the graft. Regardless of this, the TIC analysis allows objective quantification of perfusion separately from the CEUS examination. In this study, we analyzed the interoperator variance of TIC analysis between two investigators for ROI5 and ROIAnat. Overall, the agreement of TIC analysis between investigators 1 and 2 was high but in comparison to the cortex, the agreement decreased in the myelon. This is remarkable because although both investigators had different levels of experience, the results were consistent, despite the fact that renal tissue is very inhomogeneous, and different compartments were measured separately. Our results are supported by Nylund et al. who also found a low interoperator variance of TIC analysis with inflammatory bowel disease (39). We preferred the standardized 5 mm2 form ROI5 instead of the anatomic form ROIAnat. For ROIAnat, the interoperator variance for the parameters A and TTP was so high that the clinical application is not reasonable and the method ROI5 should be preferred.

TIC analyses were performed retrospectively after CEUS examination and consequently, the cine-loops lasted in some cases less than 60 s and led to a variation of the time interval for TIC analysis with a mean of 47.31 ± 15.18 s. This is due to the fact that in some patients, the arrival time in the kidney transplant was longer than in others, and the cine-loops were standardized to a length of 60 s after contrast-agent application. But this allowed us to determine the influence of the time interval of the cine-loop on the different TIC parameters. Our results showed a strong correlation between the time interval and the TIC parameter AUC. Many authors emphasize the use of AUC in the clinical context (40, 41), but if the TIC parameter is dependent on the time interval, its informative value is limited. Therefore, our results emphasize the need for a standardized start and endpoint of TIC analysis to generate a consistent time interval for TIC analysis. To date in many studies, there is no standardized length of the video clip, but this is crucial to define clear results and cutoff values of AUC and TTP in future studies.

In general, the time interval of the TIC analysis should include the contrast agent wash-in phase and representative parts of the wash-out phase. The entire wash-out phase of the contrast agent may take up to 10 min in the bolus model (18, 42), and integration of the entire wash-out phase into the TIC analysis would be too time-consuming, not practical, and inappropriate for the patient examination. With a view to a uniform time interval, the stop setting needs to be further evaluated in follow-up studies. An approach following Kay et al. would be conceivable. The authors normalized the time interval to 5 s after initiation of the contrast agent and described a correlation of AUC with eGFR 3 months after renal transplantation (43). Other experimental approaches would be a stop point 30 s after the arrival of the contrast agent to capture the cortical phase or after 60 s to capture portions of the medullary phase (12, 44).

The main limitation of this study is the limited number of subjects, and the results should be confirmed in a larger population. However, this study should generate hypotheses that should be tested in a larger cohort in a clinical context. In our study, we applied “Wash-in” kinetics as it best represents the perfusion. Eventually, patients with hyperdynamic circulation who show an early wash-out might lead to a bias in the TIC parameters. If extreme abnormalities in the visual evaluation of the perfusion kinetics were referred to as measuring errors, these CEUS examinations were excluded from the study. For the assessment of interoperator variance, the LoA has to be discussed in a clinical context (45). Consequently, till present, the assessment of interoperator variance is limited due to the lack of a generally applicable value range for TIC analysis with kidney transplants. Furthermore, no clinical parameters were included in this study, but this has to be the subject of further studies after the examination has been standardized.

Conclusion

Identifying kidney transplant recipients at increased risk for graft failure is one of the most important tasks in transplant medicine. TIC analysis could make a key contribution to improving long-term graft survival. But before TIC parameters can be used to define threshold values for good or limited future graft function, the procedure of TIC analysis should be standardized because TIC parameters are influenced by various factors. We recommended the use of an average of multiple ROIs of 5 mm2 in the cortex and myelon. The method of ROI 5 mm2 offers a standardized form and a sufficient, feasible size, which enables TIC analysis with low intraoperator and interoperator variance. The duration of the video clip should be set at 60 s after the contrast agent has reached the kidney transplant. With regard to further improvement of TIC analysis in kidney transplants, we emphasized concluding with one standardized method of ROI.

Statements

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by the Ethikkomitee Universitätsklinik Regensburg. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author contributions

SF collected, analyzed the data, wrote, reviewed, and edited the manuscript. FP conceptualized the study design, performed the CEUS examination, and edited and reviewed the manuscript. SF, EJ, TB, HT, MB, BB, and FP contributed to manuscript revision and read and approved the final version. All authors contributed to the article and approved the submitted version.

Funding

This study was supported by the University Hospital of Regensburg (ReForM B under a grant to FP).

Acknowledgments

We thank Florian Zeman from the Centre for Clinical Studies of the University Hospital of Regensburg for his assistance with the statistical and biometric analysis of the data.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    SuthanthiranMStromTB. Renal transplantation.N Engl J Med. (1994) 331:36576. 10.1056/NEJM199408113310606

  • 2.

    PortFKWolfeRAMaugerEABerlingDPJiangK. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.JAMA. (1993) 270:133943. 10.1001/jama.270.11.1339

  • 3.

    SchnuellePLorenzDTredeMvan der WoudeFJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.J Am Soc Nephrol. (1998) 9:213541. 10.1681/ASN.V9112135

  • 4.

    GastonRSCeckaJMKasiskeBLFiebergAMLeducRCosioFCet alEvidence for antibody-mediated injury as a major determinant of late kidney allograft failure.Transplantation. (2010) 90:6874. 10.1097/TP.0b013e3181e065de

  • 5.

    EineckeGSisBReeveJMengelMCampbellPMHidalgoLGet alAntibody-mediated microcirculation injury is the major cause of late kidney transplant failure.Am J Transplant. (2009) 9:252031. 10.1111/j.1600-6143.2009.02799.x

  • 6.

    NankivellBJBorrowsRJFungCL-SO’ConnellPJAllenRDMChapmanJR. The natural history of chronic allograft nephropathy.N Engl J Med. (2003) 349:232633. 10.1056/NEJMoa020009

  • 7.

    OttUWolfG. Indikation zur nierenbiopsie nach nierentransplantation.Nephrologe. (2010) 5:46672. 10.1007/s11560-009-0376-7

  • 8.

    BassiRNiewczasMABianconeLBussolinoSMerugumalaSTezzaSet alMetabolomic profiling in individuals with a failing kidney allograft.PLoS One. (2017) 12:e0169077. 10.1371/journal.pone.0169077

  • 9.

    BanasMCBöhmigGAViklickyORostaingLPJouveTGuiradoLet alA prospective multicenter trial to evaluate urinary metabolomics for non-invasive detection of renal allograft rejection (PARASOL): study protocol and patient recruitment.Front Med. (2021) 8:780585. 10.3389/fmed.2021.780585

  • 10.

    RaoulSPIpekIGMcLaughlinKYilmazSMahallatiH. Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study.AJR Am J Roentgenol. (2010) 194:W40713. 10.2214/AJR.09.2912

  • 11.

    JeongSParkSBChangIHShinJChiBHParkHJet alEstimation of renal function using kidney dynamic contrast material-enhanced CT perfusion: accuracy and feasibility.Abdom Radiol. (2021) 46:204551. 10.1007/s00261-020-02826-7

  • 12.

    SidhuPSCantisaniVDietrichCFGiljaOHSaftoiuABartelsEet alDie EFSUMB-Leitlinien und empfehlungen für den klinischen einsatz des kontrastverstärkten ultraschalls (CEUS) bei nicht-hepatischen anwendungen: update 2017 (Langversion).Ultraschall Med. (2018) 39:e244. 10.1055/a-0586-1107

  • 13.

    YangCWuSYangPShangGQiRXuMet alPrediction of renal allograft chronic rejection using a model based on contrast-enhanced ultrasonography.Microcirculation. (2019) 26:e12544. 10.1111/micc.12544

  • 14.

    RudnickMRLeonberg-YooAKLittHICohenRMHiltonSReesePP. The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk?Am J Kidney Dis. (2020) 75:10513. 10.1053/j.ajkd.2019.05.022

  • 15.

    TangM-XMulvanaHGauthierTLimAKPCosgroveDOEckersleyRJet alQuantitative contrast-enhanced ultrasound imaging: a review of sources of variability.Interface Focus. (2011) 1:52039. 10.1098/rsfs.2011.0026

  • 16.

    GauthierTPAverkiouMALeenELS. Perfusion quantification using dynamic contrast-enhanced ultrasound: the impact of dynamic range and gain on time-intensity curves.Ultrasonics. (2011) 51:1026. 10.1016/j.ultras.2010.06.004

  • 17.

    Pitre-ChampagnatSCoiffierBJourdainLBenatsouBLeguerneyILassauN. Toward a standardization of ultrasound scanners for dynamic contrast-enhanced ultrasonography: methodology and phantoms.Ultrasound Med Biol. (2017) 43:26707. 10.1016/j.ultrasmedbio.2017.06.032

  • 18.

    GreisC. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).Clin Hemorheol Microcirc. (2011) 49:13749. 10.3233/CH-2011-1464

  • 19.

    KooTKLiMY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research.J Chiropr Med. (2016) 15:15563. 10.1016/j.jcm.2016.02.012

  • 20.

    SchneiderAGGoodwinMDSchellemanABaileyMJohnsonLBellomoR. Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study.Crit Care. (2014) 18:653. 10.1186/s13054-014-0653-3

  • 21.

    WeiKLeEBinJ-PCogginsMThorpeJKaulS. Quantification of renal blood flow with contrast-enhanced ultrasound.J Am Coll Cardiol. (2001) 37:113540. 10.1016/S0735-1097(00)01210-9

  • 22.

    WangXYuZGuoRYinHHuX. Assessment of postoperative perfusion with contrast-enhanced ultrasonography in kidney transplantation.Int J Clin Exp Med. (2015) 8:18399405.

  • 23.

    YoonHEKimDWKimDKimYShinSJShinYR. A pilot trial to evaluate the clinical usefulness of contrast-enhanced ultrasound in predicting renal outcomes in patients with acute kidney injury.PLoS One. (2020) 15:e0235130. 10.1371/journal.pone.0235130

  • 24.

    LiangWXCaiMJJiangLXieYQYuanWLZhangH. Ultrasonic imaging characteristics of transplanted kidneys with delayed graft function.Genet Mol Res. (2014) 13:687884. 10.4238/2014.August.29.9

  • 25.

    CaiRTaoLLiangWLinMGuoXHuangX-E. Application of contrast-enhanced sonography on the diagnosis of acute and chronic rejection after renal transplantation.Ultrasound Q. (2020) 36:5963. 10.1097/RUQ.0000000000000449

  • 26.

    JinYYangCWuSZhouSJiZZhuTet alA novel simple noninvasive index to predict renal transplant acute rejection by contrast-enhanced ultrasonography.Transplantation. (2015) 99:63641. 10.1097/TP.0000000000000382

  • 27.

    SchwengerVKorosoglouGHinkelU-PMorathCHansenASommererCet alReal-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy.Am J Transplant. (2006) 6:60915. 10.1111/j.1600-6143.2005.01224.x

  • 28.

    AraújoNCSuassunaJHR. Time-intensity curve analysis of contrast-enhanced ultrasound is unable to differentiate renal dysfunction in the early post-transplant period - a prospective study.BMC Nephrol. (2018) 19:351. 10.1186/s12882-018-1158-0

  • 29.

    BrabrandKLangeCde EmblemKEReinholtFPSaugstadODStokkeES. Contrast-enhanced ultrasound identifies reduced overall and regional renal perfusion during global hypoxia in piglets.Invest Radiol. (2014) 49:5406. 10.1097/RLI.0000000000000053

  • 30.

    JeongSParkSBKimS-HHwangJHShinJ. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study.J Ultrasound. (2019) 22:45360. 10.1007/s40477-019-00409-x

  • 31.

    StockEPaepeDDaminetSVandermeulenEDuchateauLSaundersJHet alContrast-enhanced ultrasound examination for the assessment of renal perfusion in cats with chronic kidney disease.J Vet Intern Med. (2018) 32:2606. 10.1111/jvim.14869

  • 32.

    KihmLPBlumeCSeckingerJHankelVStofflerDMorathCet alAcute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography.Transplantation. (2012) 93:11259. 10.1097/TP.0b013e31824f3dae

  • 33.

    Álvarez RodríguezSHevia PalaciosVSanz MayayoEGómez Dos SantosVDíez NicolásVSánchez GallegoMDet alThe usefulness of contrast-enhanced ultrasound in the assessment of early kidney transplant function and complications.Diagnostics. (2017) 7:53. 10.3390/diagnostics7030053

  • 34.

    BenozziLCappelliGGranitoMDavoliDFavaliDMontecchiMGet alContrast-enhanced sonography in early kidney graft dysfunction.Transplant Proc. (2009) 41:12145. 10.1016/j.transproceed.2009.03.029

  • 35.

    FischerTMühlerMKrönckeTJLembckeARudolphJDiekmannFet alEarly postoperative ultrasound of kidney transplants: evaluation of contrast medium dynamics using time-intensity curves.Rofo. (2004) 176:4727. 10.1055/s-2004-812992

  • 36.

    FischerTFilimonowSDieckhöferJSlowinskiTMühlerMLembckeAet alImproved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer–a new method for the diagnosis of renal perfusion.Nephrol Dial Transplant. (2006) 21:29219. 10.1093/ndt/gfl313

  • 37.

    LeinonenMRRaekallioMRVainioOMRuohoniemiMOO’BrienRT. The effect of the sample size and location on contrast ultrasound measurement of perfusion parameters.Vet Radiol Ultrasound. (2011) 52:827. 10.1111/j.1740-8261.2010.01745.x

  • 38.

    Bracco Imaging.Fachinformation (Zusammenfassung der Merkmale des Arzneimittels).Midrand: SonoVue (2022).

  • 39.

    NylundKSaevikFLehSPfefferFHauskenTGiljaOH. Interobserver-analyse der CEUS abgeleiteten perfusion bei fibrotischem und entzündlichem morbus crohn.Ultraschall Med. (2019) 40:7684. 10.1055/s-0044-100492

  • 40.

    WangLWuJChengJ-FLiuX-YMaFGuoL-Het alDiagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.J Nephrol. (2015) 28:66978. 10.1007/s40620-015-0183-3

  • 41.

    ZhangQYuZXuYZengSZhangZXueWet alUse of contrast-enhanced ultrasonography to evaluate chronic allograft nephropathy in rats and correlations between time-intensity curve parameters and allograft fibrosis.Ultrasound Med Biol. (2016) 42:157483. 10.1016/j.ultrasmedbio.2016.01.028

  • 42.

    TsuruokaKYasudaTKoitabashiKYazawaMShimazakiMSakuradaTet alEvaluation of renal microcirculation by contrast-enhanced ultrasound with Sonazoid as a contrast agent.Int Heart J. (2010) 51:17682. 10.1536/ihj.51.176

  • 43.

    KayDHMazonakisMGeddesCBaxterG. Ultrasonic microbubble contrast agents and the transplant kidney.Clin Radiol. (2009) 64:10817. 10.1016/j.crad.2009.06.010

  • 44.

    BǎdulescuMRSocaciuMAMoisoiuTAndriesAIacobGBadeaR. Current status of imaging diagnosis in the transplanted kidney. a review of the literature with a special focus on contrast-enhanced ultrasonography.Med Pharm Rep. (2020) 93:13344. 10.15386/mpr-1536

  • 45.

    GriffithsPMurrellsT. Reliability assessment and approaches to determining agreement between measurements: classic methods paper.Int J Nurs Stud. (2010) 47:9378. 10.1016/j.ijnurstu.2010.03.004

Summary

Keywords

TIC-analysis, ROI, region of interest, CEUS, contrast-enhanced ultrasound, kidney transplantation, perfusion analysis

Citation

Friedl S, Jung EM, Bergler T, Tews HC, Banas MC, Banas B and Putz FJ (2022) Factors influencing the time-intensity curve analysis of contrast-enhanced ultrasound in kidney transplanted patients: Toward a standardized contrast-enhanced ultrasound examination. Front. Med. 9:928567. doi: 10.3389/fmed.2022.928567

Received

25 April 2022

Accepted

29 July 2022

Published

25 August 2022

Volume

9 - 2022

Edited by

Xiaopeng Hu, Capital Medical University, China

Reviewed by

Yi Dong, Fudan University, China; Cheng Yang, Fudan University, China

Updates

Copyright

*Correspondence: Sarah Friedl,

This article was submitted to Nephrology, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics